Analysis-Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer's prevention

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...

Novo Nordisk’s Alzheimer’s Trials Show No Significant Progress

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.